Blog

  • New Graphene Technology Matures Brain Organoids Faster, May Unlock Neurodegenerative Insights

    New Graphene Technology Matures Brain Organoids Faster, May Unlock Neurodegenerative Insights

    Key study findings include:

    • Faster development: Regular use of GraMOS helped brain organoids form stronger connections, better organized networks, and more advanced communication between neurons — even in models made from Alzheimer’s patients.
    • Safe and biocompatible: Graphene did not harm neurons or organoid structure, even over long periods.
    • Enhanced disease modeling: Early-stage Alzheimer’s organoids revealed functional differences in network connectivity and excitability when stimulated.
    • Robotic integration: Graphene-stimulated organoids were linked to a simple robot in a closed feedback loop, enabling it to respond to visual cues.

    From the lab to Alzheimer’s research and beyond

    Because stimulation accelerates neural maturation, researchers can study disease progression sooner and in a more physiologically relevant context. This could improve drug testing timelines and provide new insight into how diseases like Alzheimer’s alter brain circuitry.

    “Our technology bridges a critical gap in organoid research,” said Alex Savchenko, Ph.D., co-senior author and chief executive officer of Nanotools Bioscience. “It offers a reliable, repeatable way to activate neurons, which can transform both fundamental neuroscience and translational studies.”

    Brain meets machine

    Brain organoids interfaced with graphene become responsive to their environment and can change their neuronal networks in response to light. This acquired neuroplasticity offers a huge advantage over computer chips in future artificial intelligence (AI) applications by improving the ability of AI systems to solve complex, unforeseen problems and offering greater fault tolerance and reliability in critical applications.

    In a striking proof-of-concept, the team connected graphene-interfaced brain organoids to a robotic system equipped with sensors. When the robot detected an obstacle, it sent a signal to stimulate the organoid, which then generated a neural pattern triggering the robot to change course — completing the loop in under 50 milliseconds.

    While still far from conscious machines, this integration hints at future neuro-biohybrid systems where living neural tissue and robotics work together for advanced prosthetics, adaptive interfaces or even new forms of computation.

    This study is a major step toward unlocking the potential of graphene in neuroscience, nanotechnology and neuroengineering. The technology could lead to new ways of connecting increasingly complex brain-like tissues to each other — and even to the brain itself. The ability to control and accelerate brain organoid development opens the door to using them as powerful models for testing therapies for neurodegenerative and developmental brain disorders, where damaged connections can disrupt the brain’s ability to process and respond to information.

    Beyond disease research, the approach could be adapted for tissue engineering, offering a noninvasive, precise way to stimulate other types of lab-grown tissues. And by linking living neural networks to machines, researchers may discover how the brain’s adaptability and learning could enhance computers and robotics — with possible future applications in artificial intelligence.

    “This is only the beginning,” said Muotri. “The combination of graphene’s versatility and brain organoid biology could redefine what’s possible in neuroscience, from understanding the brain to creating entirely new technological paradigms.”

    Link to full study.

    Additional co-authors on the study include: Mariana S.A. Ferraz, Angels Almenar-Queralt, Georgia Chaldaiopoulou, Janaina Sena de Souza, Francesca Puppo and Pinar Mesci from UC San Diego School of Medicine; Teng Zhou, Michael Reiss, Honieh Hemati, Francisco Downey and Omowuyi O. Olajide from UC San Diego School of Engineering; Pragna Vasupal from NeurANO Bioscience; Volodymyr P. Cherkas from Institute of Bioorganic Chemistry at the Polish Academy of Sciences and the Bogomoletz Institute of Physiology; Prashant Narute and Dmitry Kireev from University of Massachusetts, Amherst; Carolina Thörn Perez from Universidade Federal do ABC; and, Samuel L. Pfaff from the Salk Institute for Biological Studies.

    The study was funded, in part, by the National Institutes of Health (A.S.: 1R43MH124563; A.R.M: 1R01MH128365, R01NS123642, 1R01ES033636, MH123828, MH127077, NS105969; EM: 1R43NS122666, 1R43AG076088, 5R44DA050393), Department of Defense W81XWH2110306 (to A.R.M.), the California Institute of Regenerative Medicine (DISC2-13866 to A.S.), and the Long-term program of support of the Ukrainian research teams at the Polish Academy of Sciences carried out in collaboration with the U.S. National Academy of Sciences with the financial support of external partners to V.C.

    Disclosures: Alex Savchenko and Elena Molokanova are co-founders of Nanotools Bioscience, a company focused on exploring optoelectronic properties of graphene for bioapplications. Molokanova is listed as an inventor on patents related to the graphene-based optical stimulation technology described in this study (US10137150B2, US10688127B2, CN106458601B, JP6635383B2, EP3157866B1). Alysson A. Muotri is a co-founder and has an equity interest in TISMOO, a company dedicated to genetic analysis and brain organoid modeling focusing on therapeutic applications customized for autism spectrum disorder and other neurological disorders with genetic origins. The terms of this arrangement have been reviewed and approved by the University of California San Diego in accordance with its conflict-of-interest policies. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

    Continue Reading

  • Active thyroid surveillance effective, beneficial for older patients

    Active thyroid surveillance effective, beneficial for older patients

    Older patients may benefit most from active imaging and pathology surveillance of small, low-risk papillary thyroid cancer, according to research published August 20 in JAMA Surgery

    A team led by Anna Sawka, MD, PhD, from Toronto General Hospital in Ontario, Canada, found that more than three-fourths of patients who chose active surveillance via ultrasound and blood work continued this route in the absence of disease progression or other indications for surgery at long-term follow-up. The group also found that older patients continued with surveillance more often than younger patients. 

    “We were struck by how durable active surveillance was, particularly in older patients,” Sawka told AuntMinnie.com. “The findings reinforce the central role of high-quality ultrasound imaging in safely monitoring small, low-risk thyroid cancers over time.”

    Active surveillance may be favored by some patients in managing low-risk, early-stage cancers. This makes counseling patients important, so they better understand how surveillance ties into patient age. 

    Sawka and co-authors evaluated the durability of active surveillance in patients with small, low-risk papillary thyroid cancer according to age at the time of choosing surveillance. The surveillance protocol included ultrasound exams performed in the joint departmental medical imaging department, blood work, and clinical assessment every six months for two years. This was followed by a yearly assessment if the findings were stable. The team reviewed medical records from patients at baseline and at least yearly and “made a concerted” effort to inform patients of their options. 

    For the study, the researchers focused on the overall rate of surveillance crossover to definitive treatment and the indications that led to crossover events. 

    Final analysis included 200 patients with an average age of 52 years, 155 of whom were under active surveillance and the remaining 45 of whom had immediate surgery. The team followed up with the patients for a median of 71 months. It reported no thyroid cancer-related deaths or any distant metastatic disease. 

    The overall crossover rate from surveillance reached 23.9% (n = 37), with 32 patients completing treatment, three declining surgery, and two awaiting treatment. 

    Crossover reasons included the following: 

    • Disease progression (56.8%), 

    • Patient preference (40.5%), and 

    • Ultrasound imaging limitations preventing accurate tumor measurement under active surveillance (2.6%). 

    For the ultrasound imaging reason, the team highlighted that the tumor border in one patient with Hashimoto thyroiditis was not clearly distinguishable from heterogeneous echotexture of the thyroid parenchyma.  

    The investigators also noted the following rates for five-year age-stratified cumulative overall crossover incidence: 41.5% in patients younger than 45 years, 20.9% in those aged 45 to 64 years, and 5.1% in patients aged 65 years and older (p < .001). 

    They suggested that active surveillance may be offered as a first-line management option for patients with small, low-risk papillary thyroid tumors. This could be “especially relevant” for older patients who may want to avoid surgery.  

    Sawka said the results underscore the importance of precision imaging in supporting non-surgical management pathways for low risk thyroid malignancies. 

    “In our study, active surveillance outcomes were relatively comparable to immediate surgery in terms of overall cancer control,” she added. “It is important to acknowledge that all patients in our study had thyroid cytopathology obtained by fine needle aspiration biopsy prior to enrollment, and the cytology was required to be either positive or suspicious for papillary thyroid carcinoma for inclusion in this study. In follow-up, ultrasound-guided biopsies were only performed if clinically indicated.”

    Sawka also told AuntMinnie.com that the team is continuing to follow this patient cohort as part of a larger, multicenter Canadian study. 

    “This will allow us to gather longer-term outcomes in a broader population base,” she said.

    The full study can be found here.

    Continue Reading

  • ‘Emily In Paris’ Season 5 Release Date & Photos Unveiled By Netflix

    ‘Emily In Paris’ Season 5 Release Date & Photos Unveiled By Netflix

    Andiamo! Emily in Paris Season 5 will continue the European journey of one fashionista and marketing expert when it lands on Netflix December 18.

    The fifth season, which contains 10 episodes, will arrive in a binge format at the end of the year after Season 4 was split into two parts, taking Emily out of the French capital and into Rome, Italy. Season 5 has added Venice as a new setting for the story.

    According to the logline, Lily Collins’ Emily Cooper is now the head of Agence Grateau Rome, and she faces both career and love life challenges as she adjusts to her new home.

    “But just as everything falls into place, a work idea backfires, and the fallout cascades into heartbreak and career setbacks,” Netflix’s summary continues. “Seeking stability, Emily leans into her French lifestyle, until a big secret threatens one of her closest relationships. Tackling conflict with honesty, Emily emerges with deeper connections, renewed clarity, and a readiness to embrace new possibilities.”

    In the first-look images, Collins’ sports the bob haircut that she wore when Season 4 Part 2 came out on Netflix, marking a new hairstyle for Emily, who made a big deal of cutting bangs previously. More photos can be found below.

    L-R: Lily Collins as Emily and Ashley Park as Mindy in ‘Emily In Paris’

    Caroline Dubois/Netflix

    Darren Star serves as creator, writer and executive producer on Season 5. Tony Hernandez, Lilly Burns, Andrew Fleming, Stephen Brown, Alison Brown, Robin Schiff, Grant Sloss and Joe Murphy also executive produce. Collins produces as well.

    Returning cast includes Philippine Leroy-Beaulieu (Sylvie Grateau), Ashley Park (Mindy Chen), Lucas Bravo (Gabriel), Samuel Arnold (Julien), Bruno Gouery (Luc), William Abadie (Antoine Lambert), Lucien Laviscount (Alfie), Eugenio Franceschini (Marcello), Thalia Besson (Genevieve), Paul Forman (Nico) and Arnaud Binard (Laurent G). Newcomers joining this season are Minnie Driver (Princess Jane), Bryan Greenberg (Jake), and Michèle Laroque (Yvette).

    The series is produced by MTV Entertainment Studios, Darren Star Productions, and Jax Media.

    L-R: Lily Collins as Emily and Eugenio Franceschini as Marcello in 'Emily In Paris'

    L-R: Lily Collins as Emily and Eugenio Franceschini as Marcello in ‘Emily In Paris’

    Caroline Dubois/Netflix

    L-R: Bruno Gouery as Luc and Philippine Leroy-Beaulieu as Sylvie Grateau in 'Emily in Paris'

    L-R: Bruno Gouery as Luc and Philippine Leroy-Beaulieu as Sylvie Grateau in ‘Emily in Paris’

    Giulia Parmigiani/Netflix

    L-R: William Abadie as Antoine Lambert and Lucas Bravo as Gabriel in 'Emily In Paris'

    L-R: William Abadie as Antoine Lambert and Lucas Bravo as Gabriel in ‘Emily In Paris’

    Caroline Dubois/Netflix

    L-R: William Abadie as Antoine Lambert and Lucien Laviscount as Alfie in 'Emily in Paris'

    L-R: William Abadie as Antoine Lambert and Lucien Laviscount as Alfie in ‘Emily in Paris’

    Caroline Dubois/Netflix

    L-R: Bruno Gouery as Luc and Samuel Arnold as Julien in 'Emily in Paris'

    L-R: Bruno Gouery as Luc and Samuel Arnold as Julien in ‘Emily in Paris’

    Caroline Dubois/Netflix

    L-R: Lily Collins as Emily and Eugenio Franceschini as Marcello in 'Emily in Paris'

    L-R: Lily Collins as Emily and Eugenio Franceschini as Marcello in ‘Emily in Paris’

    Giulia Parmigiani/Netflix

    Lily Collins as Emily in 'Emily in Paris'

    Lily Collins as Emily in ‘Emily in Paris’

    Giulia Parmigiani/Netflix

    Lily Collins as Emily in 'Emily in Paris'

    Lily Collins as Emily in ‘Emily in Paris’

    Giulia Parmigiani/Netflix

    Continue Reading

  • HBO & BBC Release First Look Of Drama Series HALF MAN – Warner Bros. Discovery

    HBO & BBC Release First Look Of Drama Series HALF MAN – Warner Bros. Discovery

    1. HBO & BBC Release First Look Of Drama Series HALF MAN  Warner Bros. Discovery
    2. BBC reveals first look at Richard Gadd and Jamie Bell in Half Man  BBC
    3. Baby Reindeer star’s new drama unveiled in first look  Radio Times
    4. ‘Baby Reindeer’s’ Richard Gadd Shows Off His Muscles in First Look at New HBO and BBC Series ‘Half Man’  IMDb
    5. Netflix star reveals transformation for new TV role – he looks unrecognisable  The Scottish Sun

    Continue Reading

  • October Brentford fixtures moved | Brentford FC

    October Brentford fixtures moved | Brentford FC

    All three of Brentford’s games in October have been selected for television coverage.

    The Bees’ Premier League fixtures against Manchester City, West Ham United and Liverpool will all be shown live in the UK.

    Keith Andrews’ side begin the month by welcoming Pep Guardiola’s City team to Gtech Community Stadium.

    That game, originally scheduled for Saturday 4 October, will now take place on Sunday 5 October (4.30pm kick-off) and will be televised by Sky Sports.

    An international break then precedes an away London derby against West Ham, which has been moved back two days to Monday 20 October with an 8pm kick-off, also live on Sky Sports.

    Finally, the west Londoners close October with a home match against Liverpool. Arne Slot’s side will travel to the Gtech on Saturday 25 October as scheduled, however the game will now kick-off at 12.30pm, live on TNT Sports.

    Should Liverpool play away from home in the UEFA Champions League on the previous Wednesday evening, then kick-off will be moved back to 8pm on the same Saturday evening.

    Continue Reading

  • Pragmata rethinks sci-fi shooter combat, and it owes a lot to Snake (preview)

    Pragmata rethinks sci-fi shooter combat, and it owes a lot to Snake (preview)

    Back when the PS4 and Xbox One were preparing for launch, Capcom showcased Deep Down, a game set in the future that transported players back to medieval fights from the past. That game never released, and for a while, it looked like sci-fi shooter Pragmata was destined for the same fate.

    It has been stuck in development hell for almost five years now, with barely any clarity on what the game is, since its mysterious and bizarre reveal trailer at the PS5 Showcase in June 2020. Now, in 2025, Pragmata is finally emerging from the shadows of deep space, and we went hands-on with this upcoming space game ahead of Gamescom 2025.

    Continue Reading

  • Soyuz to launch a life-science mission

    Soyuz to launch a life-science mission

    Soyuz to launch a life-science mission

    A Soyuz-2 rocket to orbit the Bion-M No. 2 satellite on a month-long mission studying the effects of micro-gravity and space radiation on various organisms, including small animals, before returning them back to Earth for analysis. Launching 12 years after its predecessor, the second spacecraft in the Bion-M series will fly the over-the-poles radiation-prone orbit sought for the deployment of the new Russian Space Station after the retirement of the ISS.

    Landing of the Bion-M1 satellite


    The Bion-M2 mission at a glance:

    Spacecraft designation Bion-M No. 2, 12KSM No. 2
    Launch vehicle Soyuz-2-1b No. M15000-059
    Payload fairing 17S13 (?)
    Launch site Baikonur, Site 31
    Launch date and time 2025 Aug. 20, 20:13:10 Moscow Time
    Spacecraft mass 6,400 kilograms
    Mission duration 30 days
    Landing site Russia, Orenburg Region
    Mission status Planned

    The second Bion-M mission

    top

    The Bion-M No. 2, a.k.a. Bion M2, project is a follow-on mission to the first Bion-M launch in 2013. In turn, the Bion-M series is a modified version of the Soviet-era life-science satellites deriving directly from the pioneering Vostok spacecraft. Thanks to solar panels and other upgrades, the Bion-M variant can perform missions lasting up to 60 days, before parachuting its ball-shaped pressurized capsule inherited from the Vostok project back to Earth.

    As of 2025, the Bion-M2 mission was planned for 30 days in a 300 by 370-kilometer orbit with an inclination 97 degrees toward the Equator, which was expected to be similar to the orbital parameters of the Russian Orbital Station, ROS, where the orbital base would experience up to 30 percent a harsher radiation environment than that present in lower-latitude orbits.

    The scientific payload aboard Bion-M2, intended for as many as 22 experiments, was known to include 75 black mice and 1.5 thousand fruit flies, as well as ants, fungi, plant seeds and algae. As before, the Russian Academy of Sciences, RAN, served as the customer for the Bion-M mission and its Institute for Medical and Biological Problems of Spaceflight, IMBP, in Moscow was the prime developer of the science program. Some of the experiments were developed with the participation of high-school students.

    Aboard Bion-M2, the scientists at IMBP were planning to monitor the mice live during the mission with special cameras and sensors embedded into the animals in order to compare their behavior and conditions with two control groups on the ground: one group in regular laboratory conditions and one in a copy of the flight containers. For the flight, the mice was placed in groups of three into five 16 by 12-centimeter cylindrical containers, known as BIOS, which were equipped with feeding mechanism delivering water gel and dry food to the animals. The system was designed to keep mice alive during and immediately after the landing.

    The return vehicle was also equipped with exterior payloads which would be exposed to the conditions of space during the orbital flight, but protected with thermal covers during the reentry to give scientists pristine samples of materials carrying the effects of space conditions. According to the Vernadsky Institute for Geochemistry and Analytical Chemistry, it provided 16 tube containers with simulated lunar soil to study its exposure to space radiation.

    As of 2018, NASA received 17 submissions from US-based organizations for flying their experiments aboard the second Bion-M under an agreement with Roskosmos, but nothing was heard about the effort after 2022.

    Bion-M No. 2 development history

    In 2004, the decadal Russian space program, covering a period from 2005 to 2015, approved three Bion-M missions between 2010 and 2016. (623) As of 2009, their launches were planned for 2011, 2013 and 2016. The second mission was expected to fly up to six months, considerably extending the flight duration of the still-planned first 30-day flight.

    By June 2011, the second Bion-M launch slipped until 2015 and the flight duration was no longer specified. After the successful return of the first satellite in May 2013, Roskosmos and IMBP officials said that the Russian space program had included a follow-on Bion-M satellite (expected to fly around 2017), along with preliminary plans to conduct experiments with animals on the Science and Power Modules, NEM, of the Russian segment of the ISS.

    In June 2013, Ravil Akhmetov, a top official at TsSKB Progress which built the spacecraft, told the ITAR-TASS news agency that Bion-M No. 2 would likely carry fish and mice during its mission between 2015 and 2017. On June 27, at a press-conference dedicated to the activities of TsSKB Progress in the first half of 2013, the head of the company Aleksandr Kirilin said that the launch of the second Bion-M satellite had been scheduled for 2016. Around the same time, there were reports that four Bion-M missions could be conducted by 2020.

    During the 40th assembly of the Committee on Space Research, COSPAR, in August 2014, Lev Zeleny, the director of the Space Research Institute, IKI, promised the launch of the second Bion-M satellite in 2019 and the launch of the third satellite around 2022. At the time, one satellite was to be inserted into a 1,000-kilometer orbit and another was to fly 575 kilometers above the Earth.

    During the drafting of the new federal program in 2015, which provisioned space funding for the period from 2016 to 2025, there was a budget request for two Bion-M missions to be launched in 2019 and 2022, however, the final version of the program postponed these flights to 2021 and 2025 respectively:

    Millions of rubles

    260.0

    200.0

    800.0

    1,500

    2,000

    1,028.0

    1,088.0

    2,414.0

    1,000.0

    2,000.0

    12,920.0

    Millions of US dollars*

    3.55

    2.73

    10.93

    20.49

    27.31

    14.04

    14.86

    32.97

    13.66

    27.32

    167.85

    In reality, the development of only one satellite got underway, but by the end of 2018, its mission had to be postponed until 2023. The third Bion-M satellite was still officially on the books and even envisioned carrying a mice-housing centrifuge for simulating different levels of micro-gravity, but there were practically no reports on the progress toward that mission.

    By 2022, the launch of Bion-M No. 2 was promised in 2024, while Bion-M No. 3 was not expected before 2027 or 2028 and even that on the condition of starting the funding of the project in 2023, which was yet to be approved.

    As of 2023, the assembly of the second Bion-M was largely completed, even though during that year the launch date was set for no later than July 31, 2024, as the developers tackled last-minute issues.

    By May 2024, the Bion-M2 launch date slipped from August to Sept. 1, 2024, and by July 2024, it was re-scheduled for March 2025. In early 2025, the mission was expected on July 20 of that year, but by April, Russian officials admitted the possibility of a delay until September 2025. By June 2025, the launch date slipped to August 25 and, by July, it was advanced to August 20.

    Bion-M2 launch campaign

    On July 23, 2025, Roskosmos reported that Bion-M No. 2 had been delivered to the Baikonur launch site in Kazakhstan. The loading of experiments with biological organisms was performed on Aug. 16, 2025.

    In the meantime, at Site 31, specialists from RKTs Progress were preparing the Soyuz-2-1b rocket. That particular vehicle was a leftover from the 14th mission with OneWeb satellites, which was abruptly cancelled in March 2022, just days after Russia’s full-scale invasion of Ukraine.

    The assembly of the payload section, which included the satellite itself and its payload fairing, was completed at Site 112 in Baikonur on Aug. 18, 2025. The payload section was then transported to the vehicle processing building at Site 31 for integration with the third stage of the Soyuz-2-1b rocket and then with the rest of the launch vehicle.

    soyuz

    A Soyuz-1-1b rocket with the Bion-M2 satellite undergoes final integration on the morning of Aug. 19, 2025.


    Due to the perishable scientific materials aboard the satellite, which were mandated to launch within 72 hours from the encapsulation of the Bion-M2 inside its payload fairing, the rollout of the rocket from the vehicle assembly building at Site 31 to the launch pad was scheduled within 24 hours from the planned launch, instead of normal two or three days prior to liftoff. The final integration of the rocket was performed on the morning of Aug. 19, 2025, immediately followed by the rollout to the pad during the same day, instead of the traditional morning hours, in order to be ready for launch in the evening hours of Aug. 20, 2025.

    Bion-M No. 2 launch profile

    A Soyuz-2-1b rocket will lift off from Site 31 in Baikonur on Aug. 20, 2025, at 20:13 Moscow Time (1:13 p.m. EDT).

    After a few seconds of vertical ascent under the power of the four boosters of the first stage and the core booster of the second stage, the rocket will head north across Northern Kazakhstan and Russia, aligning its trajectory with a near-polar orbit.

    The four strap-on boosters of the first stage should separate around two minutes after liftoff.

    The fairing protecting the payload will then split in two halves and separate during the operation of the second stage.

    Moments before the second stage completes its firing, the RD-0124 engine of the third stage will begin to fire through the inter-stage lattice structure, which moments later should separate along with the second stage.

    Just 1.5 seconds later, the tail section on the third stage will split into three segments and drop off as well.

    In the runup to the Bion-M2 launch, the authorities in the Karpinsk District of Russia’s Sverdlovsk Region issued a travel ban from Aug. 18, to Aug. 20, 2025, for an area limited by points 20 kilometers north of town of Kytlym, 10-12 kilometers northwest of Kakvinskie Pechi, 17 kilometers west of Sosnovka, 4-5 kilometers south of the border with the Denezhkin Kamen’ nature reserve and 2-3 kilometers north of Konzhakovsky Gorge.

    In previous launches of Resurs-P and CAS-500-1 satellites from Baikonur, these locations were used for dropping the second stage of the Soyuz rocket, the three segments of the aft section of the third stage and the two halves of the payload fairing.

    The Bion-M2 satellite is expected to separate from the third stage of the launch vehicle around nine minutes after liftoff from Baikonur.

    Orbital flight

    The Bion-M2 is expected to orbit the Earth for about a month, before orienting its main propulsion system against the direction of the flight to perform a braking maneuver. The engine firing should slow down the spacecraft to initiate a descent toward the atmosphere, when the Service Module will separate from the Descent Vehicle. The capsule will first perform ballistic entry into the dense atmosphere before deploying a parachute system and touching down in the grasslands of the Orenburg Region in Southern Russia. The search and rescue team, including scientists from IMBP is expected to be on hand at the landing area to recover the live animals and other experiments.

    Following the landing, some mice will be dissected at the site, followed by further dissections on the 1st, 5th, 15th and 30th days after the flight to study the effects of space conditions.

     

    insider content

    insider content

    instrument


    instrument


    instrument


    instrument


    instrument


    instrument


    instrument


    Continue Reading

  • Apple’s Accessibility Campaign Proves No Frame Needs to Be Missed

    Apple’s Accessibility Campaign Proves No Frame Needs to Be Missed

    In its latest campaign, Apple brings a deeply human lens to the power of accessibility. ‘No Frame Missed’ from TBWAMedia Arts Lab LATAM is a moving, docu-style showcase of how the iPhone 16 Pro’s Action Mode and built-in accessibility features are enabling people with Parkinson’s disease to reclaim their creative voice – one frame at a time.

    Directed by Renato Amoroso, the film captures the intimate stories of four individuals navigating life with Parkinson’s, showing how technology designed for everyone can be transformative for some.

    In Cornwall, filmmaker Brett shares his journey back behind the camera. Diagnosed with Parkinson’s at 37, he had all but stopped shooting – until Action Mode gave him back the ability to film smoothly, even with a tremor. The campaign captures a beautiful moment: Brett recording his son Dexter riding a bike for the very first time. It’s the first stable video Brett has made since his diagnosis.

    From upstate New York, we meet Marie and Bette – a mother and daughter who were both diagnosed with Parkinson’s around the same time. Bette uses the iPhone to surprise her 94-year-old mum with a heartfelt birthday film, capturing moments that would have otherwise been too difficult to record.

    And in New York City, Ellen, a Brazilian creative, documents a life-changing moment: her partner Renata’s surprise proposal. Using Voice Control and Action Mode, she captures the proposal and later shares the footage with friends and family at their wedding party.

    The campaign doesn’t just spotlight stories – it shares practical tools. Alongside the film, Apple has released a hands-on tutorial with Brett walking viewers through how to use Action Mode. Other features highlighted include Voice Control, Touch Accommodations, and the Medications app – all designed to make iPhone more usable for people with physical or motor challenges.

    With ‘No Frame Missed,’ Apple continues to blur the line between product utility and emotional storytelling – reaffirming its long-standing commitment to inclusive design, and reminding the industry what accessibility looks like when it’s baked in from the start.


    Continue Reading

  • Nap Cancelled… Garfield Kart 2 – All You Can Drift Launches “N.E.R.M.A.L.” – the Network Explosion and Racing Mayhem Analysis Log

    Nap Cancelled… Garfield Kart 2 – All You Can Drift Launches “N.E.R.M.A.L.” – the Network Explosion and Racing Mayhem Analysis Log

    Whether you’re a casual Sunday driver or a slipper-wearing drift king, it’s time to tear up the track (and help us stress-test our infrastructure while you’re at it). We want your feedback, even if it’s just “too much lag, not enough lasagna.”

    Expect high-speed races, perfectly timed drifts, and delightfully unfair power plays. Throw lasagnas, dodge traps, and crush your friends… fair and square — or not.

    Get ready to rev your engines and take on your friends in chaotic multiplayer races, using traps, boosts, and every shortcut you can find to claim victory.

    Garfield Kart 2 – All You Can Drift will launch on September 10, 2025 on Nintendo Switch, PlayStation 5, Xbox Series, and PC.

    Continue Reading

  • BBC reveals first look at Richard Gadd and Jamie Bell in Half Man

    BBC reveals first look at Richard Gadd and Jamie Bell in Half Man

    The BBC has revealed first look pictures for Half Man, the original six-episode drama from the multi award-winning Richard Gadd (Baby Reindeer, Against The Law). Filming recently wrapped and took place in and around Glasgow.

    Gadd and BAFTA award-winning actor Jamie Bell (All of Us Strangers, Rocket Man) star as ‘brothers’ Ruben and Niall respectively. Today’s first look reveals the surprise reunion between Ruben and Niall after years of estrangement, leading to an explosion of violence that catapults us back through their lives over the course of the series. Spanning almost 40 years from the 1980s to the present day, Mitchell Robertson (Curfew, Mayflies) and Stuart Campbell (SAS Rogue Heroes, The Winter King) play Niall (Robertson) and Ruben (Campbell) in their younger years.

    Half Man explores the highs and lows of Ruben and Niall’s relationship, from meeting them as troubled teenagers to witnessing their falling out as adults – with all the good, bad, terrible, funny, angry, and challenging moments along the way. The series will capture the wild energy of a changing city – a changing world, even – and plumb the depths of what it means to be a man.

    Previously announced as starring in the series are Neve McIntosh (Tin Star, Chemistry of Death) as Niall’s mother Lori, and Marianne McIvor (Screw, The Nest) as Ruben’s mother Maura. Rounding out the cast for Half Man are Charlie De Melo (Rivals), Bilal Hasna (The Agency), Julie Cullen (Traces), Amy Manson (The Nevers), Philippine Velge (The Serpent Queen), Stuart McQuarrie (The Rig), Piers Ewart (The Primrose Railway Children), Scot Greenan (T2 Trainspotting), and newcomers Charlotte Blackwood and Calum Manchip.

    Half Man (6×45) is created, written and executive produced by Richard Gadd, and directed by Alexandra Brodski (Somewhere Boy, Rivals) and Eshref Reybrouck (Ferry: The Series, Cheyenne & Lola).

    The series is made by Mam Tor Productions (a Banijay UK company) for the BBC, BBC Scotland and HBO. Banijay Rights handles international distribution outside of BBC and HBO rights. Half Man is supported by Screen Scotland.

    Half Man will air in 2026 on BBC iPlayer, BBC One and BBC Scotland in the UK & Ireland, and on HBO Max in the US, Latin America and Europe.

    HC2

    Follow for more

    Continue Reading